NEW YORK CITY, NY / ACCESSWIRE / January 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vicor Corporation ("Vicor" or "the Company") (NASDAQ:VICR). Investors who purchased Vicor securities prior to April 26, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/VICR.
NEW YORK CITY, NY / ACCESSWIRE / January 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vicor Corporation ("Vicor" or "the Company") (NASDAQ:VICR). Investors who purchased Vicor securities prior to April 26, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/VICR.
NEW YORK CITY, NY / ACCESSWIRE / December 31, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vicor Corporation ("Vicor" or "the Company") (NASDAQ:VICR). Investors who purchased Vicor securities prior to April 26, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/VICR.
NEW YORK CITY, NY / ACCESSWIRE / December 30, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vicor Corporation ("Vicor" or "the Company") (NASDAQ:VICR). Investors who purchased Vicor securities prior to April 26, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/VICR.
NEW YORK, NY / ACCESSWIRE / December 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vicor Corporation ("Vicor" or "the Company") (NASDAQ:VICR). Investors who purchased Vicor securities prior to April 26, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/VICR.
NEW YORK, NY / ACCESSWIRE / December 24, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vicor Corporation ("Vicor" or "the Company") (NASDAQ:VICR). Investors who purchased Vicor securities prior to April 26, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/VICR.
NEW YORK, NY / ACCESSWIRE / December 22, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vicor Corporation ("Vicor" or "the Company") (NASDAQ:VICR). Investors who purchased Vicor securities prior to April 26, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/VICR.
NEW YORK, NY / ACCESSWIRE / December 18, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vicor Corporation ("Vicor" or "the Company") (NASDAQ:VICR). Investors who purchased Vicor securities prior to April 26, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/VICR.
NEW YORK, NY / ACCESSWIRE / December 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vicor Corporation ("Vicor" or "the Company") (NASDAQ:VICR). Investors who purchased Vicor securities prior to April 26, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/VICR.
NEW YORK, NY / ACCESSWIRE / December 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vicor Corporation ("Vicor" or "the Company") (NASDAQ:VICR). Investors who purchased Vicor securities prior to April 26, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/VICR.
Vicor's stock is irrationally overvalued despite years of underperformance and flat revenue growth, failing to capitalize on high-growth markets like HPC and AI. Q3 revenue was -13.5% yoy and the book-to-bill ratio below 1, indicating weak order growth. Q3 backlog was down -13.8% yoy. Despite the weak financial results, VICR's forward P/E = 1108x, more than 20x that of AI market leader Nvidia.
Vicor Corporation (NASDAQ:VICR ) Q3 2024 Earnings Conference Call October 22, 2024 5:00 PM ET Company Participants Jim Schmidt – Chief Financial Officer Phil Davies – Corporate Vice President, Global Sales and Marketing Patrizio Vinciarelli – Chief Executive Officer Jim Schmidt – Chief Financial Officer Conference Call Participants Quinn Bolton – Needham & Company Jon Tanwanteng – CJS Securities Richard Shannon – Craig-Hallum Don McKenna – D.B. McKenna & Co. Jon Gruber – Lagunitas Investments Alan Hicks – Ainsley Capital Management James Liberman – American Trust Investment Services Operator Good day everyone and thank you for standing by.